Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 1 medicine
All medicines with Comarketed with interferon alfa-2b
Every register, a page at a time. Strengths and packs are on each medicine’s page.
1 result
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| RebetolCombination | United States | 200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy**, 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Merck Sharp Dohme |
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1